Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1618-7601
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany ; volume:16 ; number:5 ; day:25 ; month:5 ; year:2014 ; pages:471-488 ; date:6.2015
The European journal of health economics ; 16, Heft 5 (25.5.2014), 471-488, 6.2015
- Urheber
-
Damm, Oliver
Eichner, Martin
Rose, Markus Andreas
Knuf, Markus
Wutzler, Peter
Liese, Johannes Günter
Krüger, Hagen
Greiner, Wolfgang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10198-014-0586-4
- URN
-
urn:nbn:de:101:1-2019102818185899355444
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Damm, Oliver
- Eichner, Martin
- Rose, Markus Andreas
- Knuf, Markus
- Wutzler, Peter
- Liese, Johannes Günter
- Krüger, Hagen
- Greiner, Wolfgang
- SpringerLink (Online service)
Ähnliche Objekte (12)
A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness
Influenza vaccination should have no border: cost-effectiveness of cross-border subsidy
Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1
Cost-effectiveness of seasonal influenza vaccination of children in China: a modeling analysis
Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England
The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study
The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study
An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission
Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation
A single-dose of intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate promotes protective mucosal and systemic immunity
Improved hatchability and efficient protection after in ovo vaccination with live-attenuated H7N2 and H9N2 avian influenza viruses
Influenza vaccination in pediatric age
A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness
Influenza vaccination should have no border: cost-effectiveness of cross-border subsidy
Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1
Cost-effectiveness of seasonal influenza vaccination of children in China: a modeling analysis
Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England
The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study
The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study
An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission
Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation
A single-dose of intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate promotes protective mucosal and systemic immunity
Improved hatchability and efficient protection after in ovo vaccination with live-attenuated H7N2 and H9N2 avian influenza viruses
Influenza vaccination in pediatric age
A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness
Influenza vaccination should have no border: cost-effectiveness of cross-border subsidy
Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1
Cost-effectiveness of seasonal influenza vaccination of children in China: a modeling analysis
Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England
The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study
The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study
An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission
Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation
A single-dose of intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate promotes protective mucosal and systemic immunity
Improved hatchability and efficient protection after in ovo vaccination with live-attenuated H7N2 and H9N2 avian influenza viruses